
Altium Capital
North America, New York, United States, New York
Description
Altium Capital is a healthcare investment firm focusing on the development of stage public mid-and small-cap equities.
Investor Profile
Altium Capital has backed more than 18 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 6% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series B, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Canada, Australia.
- Strong thematic focus on Biotechnology, Therapeutics, Health Care.
Stage Focus
- Post Ipo Equity (56%)
- Series B (11%)
- Series Unknown (11%)
- Series D (6%)
- Seed (6%)
- Series C (6%)
- Series A (6%)
Country Focus
- United States (72%)
- Canada (11%)
- Australia (11%)
- Israel (6%)
Industry Focus
- Biotechnology
- Therapeutics
- Health Care
- Biopharma
- Pharmaceutical
- Life Science
- Medical
- Genetics
- Clinical Trials
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Altium Capital frequently co-invest with?
Which angels does Altium Capital often collaborate with?
What are some of recent deals done by Altium Capital?
Find More Investors Like Altium Capital
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides










